Optima XE - 90 Ultracentrifuge

The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition for the acquisition of an Optima XE - 90 Ultracentrifuge. This ultracentrifuge is intended to replace an aging unit that has reached end of life and will be used for cell and virus preparations that require high speed sedimentation and separation. The contract will be awarded to Beckman Coulter, Inc. • The ultracentrifuge will be used for cell and virus preparations • The contract will be awarded without full and open competition • The acquisition is classified under NAICS code 334516 • The contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01